APOA5 and metabolic dysfunction-associated steatotic liver disease: In this research, after systematically investigating the association of ApoA5 level, metabolic syndrome, and NAFLD, we found that serum ApoA5 levels have no significant correlation with metabolic syndrome but we observed a higher level of ApoA5 in patients with hyperglycemia, which is contrary to what Ishihara et al. once reported [29].